$6.61
-0.24-3.5%
Last update: Nov 10, 4:27 PM
Ocular Therapeutix Inc
OCULNASDAQ
The average analyst price target for Ocular Therapeutix is $22.38, 238.6% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $14 to $31. The latest change came on Nov 10, 2026, when HC Wainwright & Co. raised its price target on Ocular Therapeutix from $25 to $28 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months
